XOMAP vs ZNTL

XOMA Royalty Corporation - 8.62 vs Zentalis Pharmaceuticals, Inc. — Valuation Comparison 2026

XOMAP

Pharmaceutical Preparations
XOMA Royalty Corporation - 8.62
Quality
8.2
out of 10
Value Trap
20
SAFE
Price
$25.45
Last close
Models
13/13
Active
VS

ZNTL

Pharmaceutical Preparations
Zentalis Pharmaceuticals, Inc.
Quality
5.0
out of 10
Value Trap
18
SAFE
Price
$4.00
Last close
Models
10/13
Active

Model-by-Model Comparison

ModelType XOMAP Fair ValueXOMAP Upside ZNTL Fair ValueZNTL Upside
Bayesian DCF Intrinsic $18.97 -25.2% $1.14 -71.6%
Earnings Power Value Intrinsic $4.93 -80.6% — —
EROIC Spread Intrinsic $•••.•• ••.•% $•••.•• ••.•%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
Markov DDM Intrinsic $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $2.30 -91.0% $2.99 -25.3%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
RCMH-DCF Intrinsic $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for XOMAP vs ZNTL — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

XOMAP vs ZNTL — Which Stock Is More Undervalued?

XOMAP scores higher with a 8.2/10 quality rating vs ZNTL's 5.0/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing XOMA Royalty Corporation - 8.62 (XOMAP) and Zentalis Pharmaceuticals, Inc. (ZNTL) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

XOMAP currently trades at $25.45 with a QOC of 8.2/10, while ZNTL trades at $4.00 with a QOC of 5.0/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).

XOMAP
View Full XOMA Royalty Corporation - 8.62 Analysis →
ZNTL
View Full Zentalis Pharmaceuticals, Inc. Analysis →